Abstract
A large percentage of Americans are plagued by cancer. In the United States, one third of females and one half of males face the condition sometime in their lifetime. One type of cancer that has adversely impacted the lives of many on a multinational scale is breast cancer (BC). In order to effectively battle and prevent the condition of BC, it is critical to obtain a better understanding of the biology of BC and its metastases. An important step to gain better understanding is by studying risk factors. Under this category, it is important to consider both occupational hazards and genetic predispositions. Additionally, drugs are ever-important in the fight against any disease. In the fight against BC, it is important to be aware of new drugs for BC prevention and cure. However, older drugs should not be disregarded, and thus, studies should continue to search for new information concerning their side effects and uses. Lastly, since 90 % of cancer deaths occur due to metastases, this aspect of cancer cannot be disregarded. Prevention and treatment methods for BC metastases must also be considered. Thus, this article will represent discussion on risk factors, information about new and existent drugs, and treatment and prevention for BC metastases, especially to bones and the brain. This article will also discuss new ways to synergize existing conventional drugs and preventive technologies in order to achieve optimal management strategies for eradicating BC.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Kobayashi LC, Limburg H, Miao Q, Woolcott C, Bedard LL, Massey TE et al (2012) Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: influence on prostate cancer risk and interactions. Front Oncol 2:100
Pollan M, Lope V, Miranda-Garcia J, Garcia M, Casanova F, Sanchez-Contador C et al (2012) Adult weight gain, fat distribution and mammographic density in Spanish pre- and post-menopausal women (DDM-Spain). Breast Cancer Res Treat 134:823–838
Cazzaniga M, Varricchio C, Montefrancesco C, Feroce I, Guerrieri-Gonzaga A (2012) Fenretinide (4-HPR): a preventive chance for women at genetic and familial risk? J Biomed Biotechnol 2012:172897
Coviello AD, Haring R, Wellons M, Vaidya D, Lehtimaki T, Keildson S et al (2012) A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple loci implicated in sex steroid hormone regulation. PLoS Genet 8:e1002805
Mohr SB, Gorham ED, Alcaraz JE, Kane CI, Macera CA, Parsons JK et al (2012) Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinology 4:152–157
Smolarek AK, Suh N (2011) Chemopreventive activity of vitamin E in breast cancer: a focus on gamma- and delta-tocopherol. Nutrients 3:962–986
Bougie O, Weberpals JI (2011) Clinical considerations of B. Int J Surg Oncol 2011:374012
Roetzheim RG, Ferrante JM, Lee JH, Chen R, Love-Jackson KM, Gonzalez EC et al (2012) Influence of primary care on breast cancer outcomes among medicare beneficiaries. Ann Fam Med 10:401–411
Moller P (2004) Towards evidence-based management of inherited breast and breast-ovarian cancer. Hered Cancer Clin Pract 2:11–16
Pasanisi P, Hedelin G, Berrino J, Chang-Claude J, Hermann S, Steel M et al (2009) Oral contraceptive use and BRCA penetrance: a case-only study. Cancer Epidemiol Biomarkers Prev 18:2107–2113
Salhab M, Bismohun S, Mokbel K (2010) Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery. BMC Women’s Health 10:28
Aft RL, Naughton M, Trinkaus K, Weilbaecher K (2012) Effect of (Neo)adjuvant zoledronic acid on disease-free and overall survival in clinical stage II/III breast cancer. Br J Cancer 107:7–11
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T et al (2012) Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 62:220–241
Nelson HD, Huffman LH, Fu R, Harris EL (2005) Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 143:362–379
Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB (2011) Cigarette smoking and the incidence of breast cancer. Arch Intern Med 171:125–133
Pieta B, Chmaj-Wierzchowska K, Opala T (2012) Life style and risk of development of breast and ovarian cancer. Ann Agric Environ Med 19:379–384
Hunter DJ, Colditz GA, Hankinson SE, Malspeis S, Spiegelman D, Chen W et al (2010) Oral contraceptive use and breast cancer: a prospective study of young women. Cancer Epidemiol Biomarkers Prev 19:2496–2502
Huang Y, Kang M, Li H, Li JY, Zhang JY, Liu LH et al (2012) Combined performance of physical examination, mammography, and ultrasonography for breast cancer screening among Chinese women: a follow-up study. Curr Oncol 19:eS22–eS30
Hoffman A, Pellenberg R, Drendall CI, Seewaldt V (2012) Comparison of random periareolar fine needle aspirate versus ductal lavage for risk assessment and prevention of breast cancer. Curr Breast Cancer Rep 4:180–187
Litton JK, Bevers TB, Arun BK (2012) Exemestane in the prevention setting. Ther Adv Med Oncol 4:107–112
Bersini S, Jeon JS, Dubini G, Arrigoni C, Chung S, Charest JL et al (2014) A microfluidic 3D in vitro model for specificity of breast cancer metastasis to bone. Biomaterials 35:2454–2461
Qin C, He B, Dai W, Zhang H, Wang X, Wang J et al (2014) Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes. Mol Pharm. doi:10.1021/mp400691z
Bendinelli P, Maroni P, Matteucci E, Luzzati A, Perrucchini G, Desiderio MA (2014) Microenvironmental stimuli affect Endothelin-1 signaling responsible for invasiveness and osteomimicry of bone metastasis from breast cancer. Biochim Biophys Acta 1843:815–826
Fazilaty H, Mehdipour P (2014) Genetics of breast cancer bone metastasis: a sequential multistep pattern. Clin Exp Metastasis 31(5):595–612
Vona-Davis L, Rose DP, Gadiyaram V, Ducatman B, Hobbs G, Hazard H et al (2014) Breast cancer pathology, receptor status, and patterns of metastasis in a rural Appalachian population. J Cancer Epidemiol 2014:170634
Flores IL, Dos Santos-Silva AR, Coletta RD, Vargas PA, Lopes MA (2014) Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis. Oral Surg Oral Med Oral Pathol Oral Radiol 117:e264–e268
Park SY, Kim HJ, Kim KR, Lee SK, Lee CK, Park KK et al (2014) Betulinic acid, a bioactive pentacyclic triterpenoid, inhibits skeletal-related events induced by breast cancer bone metastases and treatment. Toxicol Appl Pharmacol 275:152–162
Salhia B, Kiefer J, Ross JT, Metapally R, Martinez RA, Johnson KN et al (2014) Integrated genomic and epigenomic analysis of breast cancer brain metastasis. PLoS One 9:e85448
Wu X, Luo B, Wei S, Luo Y, Feng Y, Xu J et al (2013) Efficiency and prognosis of whole brain irradiation combined with precise radiotherapy on triple-negative breast cancer. J Cancer Res Ther 9(Suppl):S169–S172
Saha A, Ghosh SK, Roy C, Choudhury KB, Chakrabarty B, Sarkar R (2013) Demographic and clinical profile of patients with brain metastases: a retrospective study. Asian J Neurosurg 8:157–161
Gil-Gil MJ, Martinez-Garcia M, Sierra A, Conesa G, Del BS, Gonzalez-Jimenez S et al (2014) Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline. Clin Transl Oncol 16(5):436–446
Do J, Foster D, Renier C, Vogel H, Rosenblum S, Doyle TC et al (2014) Ex vivo Evans blue assessment of the blood brain barrier in three breast cancer brain metastasis models. Breast Cancer Res Treat 144:93–101
Khanfir A, Lahiani F, Bouzguenda R, Ayedi I, Daoud J, Frikha M (2013) Prognostic factors and survival in metastatic breast cancer: a single institution experience. Rep Pract Oncol Radiother 18:127–132
Conflict of Interest
All the authors declare no competing conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Nizam, M., Haq, S., Ali, S., Suresh, R., Mohammad, R.M., Sarkar, F.H. (2014). Epidemiology, Risk Factors, Treatment, and Prevention of Breast Cancer Metastases. In: miRNAs and Target Genes in Breast Cancer Metastasis. SpringerBriefs in Cancer Research. Springer, Cham. https://doi.org/10.1007/978-3-319-08162-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-08162-5_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-08161-8
Online ISBN: 978-3-319-08162-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)